144 related articles for article (PubMed ID: 8683171)
21. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
22. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
[TBL] [Abstract][Full Text] [Related]
23. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
24. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
Bagge L; Borowiec JW; Thelin S; Hultman J
Scand Cardiovasc J; 1997; 31(6):275-81. PubMed ID: 9498931
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of the effect on clinical outcome of the use of an open circuit and the use of a closed circuit in cardiopulmonary bypass for a graft replacement of the descending thoracic or thoracoabdominal aorta.
Fukada J; Morishita K; Ingu A; Kawaharada N; Fujisawa Y; Hasegawa T; Abe T
Surg Today; 2004; 34(1):11-5. PubMed ID: 14714222
[TBL] [Abstract][Full Text] [Related]
26. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
[TBL] [Abstract][Full Text] [Related]
27. The effect of a cardiopulmonary bypass system with biocompatible coating on fibrinogen levels determined by the TEG--functional fibrinogen method: preliminary results.
Fluger I; Maderová K; Simek M; Hájek R; Zapletalová J; Lonsky V
Perfusion; 2011 Nov; 26(6):503-9. PubMed ID: 21742756
[TBL] [Abstract][Full Text] [Related]
28. [The significance of heparin concentration measurement during cardiopulmonary bypass--effect of heparin-coated circuit during normothermic bypass].
Komiya T; Ban K; Yamazaki K; Ishii O; Nakamura T; Kanzaki Y
Nihon Kyobu Geka Gakkai Zasshi; 1997 Nov; 45(11):1810-5. PubMed ID: 9430957
[TBL] [Abstract][Full Text] [Related]
29. Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits.
Baba T; Morisita K; Sakata J; Ito T; Hachiro Y; Kazui T; Abe A; Komatu S
Artif Organs; 1997 Jul; 21(7):779-81. PubMed ID: 9212957
[TBL] [Abstract][Full Text] [Related]
30. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
Kuitunen AH; Heikkilä LJ; Salmenperä MT
Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
[TBL] [Abstract][Full Text] [Related]
31. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
[TBL] [Abstract][Full Text] [Related]
32. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
[TBL] [Abstract][Full Text] [Related]
34. Heparin-coated circuits (Duraflo II) with reduced versus full anticoagulation during coronary artery bypass surgery.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Card Surg; 2003; 18(2):140-6. PubMed ID: 12757341
[TBL] [Abstract][Full Text] [Related]
35. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
[TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass.
Stammers AH; Christensen KA; Lynch J; Zavadil DP; Deptula JJ; Sydzyik RT
J Extra Corpor Technol; 1999 Sep; 31(3):135-41. PubMed ID: 10847956
[TBL] [Abstract][Full Text] [Related]
37. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose.
Borowiec J; Thelin S; Bagge L; Hultman J; Hansson HE
Scand J Thorac Cardiovasc Surg; 1992; 26(3):177-85. PubMed ID: 1287831
[TBL] [Abstract][Full Text] [Related]
38. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
[TBL] [Abstract][Full Text] [Related]
39. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
Mahmood S; Bilal H; Zaman M; Tang A
Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288
[TBL] [Abstract][Full Text] [Related]
40. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
